Meer informatie over geneesmiddelen kunt u vinden in de Geneesmiddelenatlas.
Algemene informatie over nagels en nagelaandoeningen
www.huidziekten.nl
www.erj.ersjournals.com
D'Alessandro, A, G. Muzi, A., Monaco, S., Filiberto, A., Barboni and G. Abbritti (2001), “Yellow nail syndrome: does protein leakage play a role”, European Respiratory Journal, vol. 17, pp. 149-152. (Engels)
www.ncbi.nlm.nih.gov
Johns Hopkins University (2005), Yellow Nail Syndrome, [Online], [Accessed: 2005, June 10]. (Engels)
www.ncbi.nlm.nih.gov
Tosti, A., Piraccini, B.M. and Iorizzo, M. (2002),”Systemic itraconazole in the yellow nail syndrome”, Br J Dermatol, vol. 146, no. 6, june, pp. 1064-1067
(Engels)
archderm.ama-assn.org
Williams, H.C., Buffham, R. and du Vivier, A. (1991), ”Successful use of topical vitamin E solution in the treatment of nail changes in yellow nail syndrome”, Arch Dermatol, vol. 127, no. 7, July, pp. 1023 - 1028.
www.patient.co.uk
[AccessedPatient plus (2004), Yellow Nail Syndrome, [Online], : 2005, June 10]. (Engels)
Dawber, R, P. and Baran, R (1984), “Investigations and some physiochemical properties of nails”, in: Diseases of the nails and their management, Blackwell scientific publications, London. (Engels)
Dawber, R. P. R., Baran, R., Berker, D. (1998), Disorders of nails, in: Champion, R, H. Burton, J, L. Burns, D, A. (eds), Rook, Wikinson, Eblings Textbook of Dermatology, vol. 2, 6th ed, Blackwell science Ltd, London. (Engels)
Richard, Scher, K. and Ralph, D.C. (1990), Nails: Therapy, Diagnosis, surgery, W.B. Saunders Company, New York. (Engels)
| Bron: LSHTM | Copyright: Medic Info | Datum: 29/12/2008 | Disclaimer |